Ticker Details
Vera Therapeutics, Inc.
IPO Date:	May 14, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.96B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.78 | 3.37%
Avg Daily Range (30 D):	$1.07 | 2.38%
Avg Daily Range (90 D):	$1.19 | 3.16%

Institutional Daily Volume
Avg Daily Volume:	.57M
Avg Daily Volume (30 D):	.86M
Avg Daily Volume (90 D):	1.17M

Trade Size
Avg Trade Size (Sh.):	72
Avg Trade Size (Sh.) (30 D):	53
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	2,032
Avg Institutional Trade:	$2.31M
Avg Institutional Trade (30 D):	$2.82M
Avg Institutional Trade (90 D):	$2.67M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.63M
Avg Closing Trade (30 D):	$4.67M
Avg Closing Trade (90 D):	$5.38M
Avg Closing Volume:	119.05K

News

Dec 10, 2025 @ 1:57 AM Vera Therapeutics Announces Pricing of Public Offe... Source: Vera Therapeutics

Nov 21, 2025 @ 3:50 PM BK Virus Infection Market Trends, Strategies and B... Source: Researchandmarkets.Com

Nov 7, 2025 @ 11:27 PM Vera Therapeutics Submits Biologics License Applic... Source: Vera Therapeutics

Aug 6, 2025 @ 6:05 AM Vera (VERA) Q2 Net Loss Widens 127% Source: Jesterai

Jul 10, 2025 @ 11:05 PM Vera Therapeutics Reports Inducement Grants Under ... Source: Vera Therapeutics, Inc.

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-3.99	$-1.26	$-1.2
Diluted EPS	$-3.99	$-1.26	$-1.2
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-251.94M	$-80.29M	$-76.53M
Operating Income / Loss	$-270.18M	$-83.93M	$-80.14M
Cost of Revenue
Net Cash Flow	$30.52M	$8.65M	$-5.97M
PE Ratio